This brand name is authorized in Finland, United Kingdom
The drug INVICORP contains a combination of these active pharmaceutical ingredients (APIs):
1
Phentolamine
UNII Y7543E5K9T - PHENTOLAMINE MESYLATE
|
Phentolamine is a competitive non-selective α1- and α2-adrenergic receptor blocker of relatively short duration of action. It causes vasodilatation and a fall in blood pressure resulting from the blockade of both post-junctional vascular α1- and α2-adrenoceptors. It also antagonises the vasoconstrictor response to noradrenaline and adrenaline infusions. |
2
Aviptadil
UNII A67JUW790C - AVIPTADIL
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
G04BE30 | Combinations | G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 042031, 084753 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 307377 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.